
InDex Pharmaceuticals Holding AB (publ)
SSE:INDEX.ST
Overview | Financials
Company Name | InDex Pharmaceuticals Holding AB (publ) |
Symbol | INDEX.ST |
Currency | SEK |
Price | 0.244 |
Market Cap | 129,975,872 |
Dividend Yield | 0% |
52-week-range | 0.198 - 0.926 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Johan Gileus |
Website | https://www.indexpharma.com |
An error occurred while fetching data.
About InDex Pharmaceuticals Holding AB (publ)
InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD